Obese Patients With Untreated Dyslipidemias
NCT00029835
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1033
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Dyslipidemia
Interventions
DRUG:
Rimonabant (SR141716)
Sponsor
Sanofi